{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:23:33Z","timestamp":1770434613278,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.drugalcdep.2009.07.006","type":"journal-article","created":{"date-parts":[[2009,8,30]],"date-time":"2009-08-30T08:09:29Z","timestamp":1251619769000},"page":"256-258","source":"Crossref","is-referenced-by-count":31,"title":["Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study"],"prefix":"10.1016","volume":"105","author":[{"given":"Lara A.","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Oslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2009.07.006_bib1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE Study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drugalcdep.2005.11.024","article-title":"Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis","volume":"83","author":"Arias","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib6","first-page":"263","article-title":"Development of a composite measure for assessing alcohol treatment outcome: operationalization and validation","volume":"23","author":"Cisler","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.ALC.0000078020.92938.0B","article-title":"Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE Study): a pilot feasibility study","volume":"27","author":"COMBINE Study Research Group","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1530-0277.2003.tb02873.x","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods","volume":"27","author":"COMBINE Study Research Group","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1530-0277.1996.tb05264.x","article-title":"Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991","volume":"20","author":"Litten","year":"1996","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15288\/jsas.1994.s12.112","article-title":"Measurement of drinking behavior using the Form 90 family of instruments","volume":"12","author":"Miller","year":"1994","journal-title":"J. Stud. Alcohol. Suppl."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib12","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1530-0277.2001.tb02170.x","article-title":"Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes","volume":"25","author":"Monti","year":"2001","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1360-0443.2001.961115654.x","article-title":"Naltrexone for alcohol dependence: a randomized controlled trial","volume":"96","author":"Morris","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence. A controlled study","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1530-0277.2008.00846.x","article-title":"OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach","volume":"33","author":"Oroszi","year":"2009","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/01.ALC.0000148114.34000.B9","article-title":"A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans","volume":"28","author":"Ray","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","article-title":"Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","volume":"64","author":"Ray","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib19","series-title":"The SAS System for Windows","author":"SAS Institute Inc.","year":"2003"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001867.pub2","article-title":"Opioid antagonists for alcohol dependence","author":"Srisurapanont","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib21","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/ng1437","article-title":"Will tomorrow's medicines work for everyone?","volume":"36","author":"Tate","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.15288\/jsa.1997.58.358","article-title":"The reliability of Form 90: an instrument for assessing alcohol treatment outcome","volume":"58","author":"Tonigan","year":"1997","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.drugalcdep.2009.07.006_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609002865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609002865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T14:50:49Z","timestamp":1685112649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871609002865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0376871609002865"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.07.006","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}